“…Whereas it was previously suggested that oral and genital infections were primarily associated with HSV-1 and HSV-2, respectively, an increase in the incidence of genital HSV-1 infection has been seen over the past 20 years (4,9,16,18,29). As a result of the clinical significance of the pathogens in terms of prevalence and morbidity, a number of investigative teams have developed vaccines to HSV-1 or HSV-2, some of which have been evaluated against HSV-1 and/or HSV-2 (2,5,11,15,20,22,26,32,33,41).…”